A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery

Obesity Surgery

Volumn 12, Issue 1, 2002, Pages 19-24

  Scholten, Donald J ^a   Hoedema, Rebecca M ^a   Scholten, Sarah E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bariatric surgery; Deep venous thrombosis prophylaxis; Low molecular weight heparin; Morbid obesity

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BARIATRIC SURGERY; BLEEDING; BODY MASS; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MORBID OBESITY; MORBIDITY; OPERATION DURATION; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SURGICAL MORTALITY; SURGICAL RISK;

ADULT; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HUMANS; MALE; OBESITY, MORBID; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0036174636     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089202321144522     Document Type: Article

References (34)

1. Risk factors in pulmonary embolism
2. The early diagnosis of thromboembolism by ultrasound
3. Postoperative venous thrombosis
4. The postmortem incidence of pulmonary embolism in a hospital population
5. Prevention of venous thromboembolism
6. Prophylaxis of venous thromboembolism in bariatric patients
7. Death from pulmonary thromboembolism in severe obesity: Lack of association with established genetic and clinical risk factors
8. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism
9. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years
10. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery
11. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
12. Unfractionated and low-molecular-weight heparin. Comparison and current recommendations
13. Hermarin Antifactor Xa levels in morbily obese patients receiving Lovenox® prophylaxis
14. Clinical assessment of venous thromboembolitic risk in surgery patients
15. A guide to venous thromboembolism risk factor assessment
16. The disease burden associated with overweight and obesity
17. Annual deaths attributable to obesity in the United States
18. Social and economic effects of body weight in the United States
19. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Conference Statement
20. Bariatric surgery for morbid obesity
21. A decade of change in obesity surgery
22. Is morbid obesity a risk factor for postoperative venous thromboembolism?
23. Predicting failure of low-dose prophylactic heparin in general surgical procedures
24. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicenter trial with venographic assessment
25. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency
26. Cost effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis
27. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
28. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients
29. Low molecular weight heparins: Current use and indications
30. Prophylaxis from thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: A prospective, randomized trial
31. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement; double-blind randomized comparison of enoxaparin versus placebo
32. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
33. Deep venous thrombosis: A continuing problem
34. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis